-
Cost to Treat COVID Increased by 26 Percent Over Two Years of Pandemic: Report -
WHO Recommends No Changes to Current COVID Vaccine -
Health Minister Encourages Australians to Receive New XBB 1.5 Jab -
Top Chinese Officials Die of ‘Illness’ as COVID Spreads Through China -
New Wave of COVID-19 Infections Hits China -
Omicron’s New Variant Arcturus Rapidly Spreading Worldwide, Causing Pink Eye -
People ‘Up to Date’ With COVID-19 Vaccines More Likely to Be Infected: Study -
FDA Panel Recommends Updating COVID-19 Vaccines -
China Facing New Wave of COVID-19 Infections -
Omicron BA.5 Insights: New Model Reveals Primary Cause for High Infection Rates -
Ontario Had More COVID-19 Deaths and Hospitalizations in 2022 Than 2021: Report -
Hospital Mask Mandate Did Little to Stop Omicron From Infecting Patients: UK Study -
China Reports 1st Case of Dual Infection by Omicron Subvariants -
Fourth COVID Booster Shot Now Recommended for Vulnerable Groups: Federal Panel -
Prominent Virologist Criticizes CCP’s Coverup of COVID Data, Says Virus Could Have Mutated in China -
Is XBB.1.5 the Most Transmissible Variant? -
Moderna and Regulatory Agencies Caught Leaving Out Bivalent Vaccine Data, Physicians Skeptical of Timing -
Omicron Subvariant XBB.1.5 Could Be More Likely to Infect Vaccinated: NYC Health Officials -
Medical System in China’s Hebei Province Is Collapsing: Doctor -
NTD Good Morning (Dec. 27): Southwest Airlines Cancellation Chaos; ‘White Lungs’ Reappear in China COVID Cases -
Senior Academicians from Chinese Academy of Sciences and Engineering Die Amid COVID Wave -
Leaked China Docs Estimate 250 Million COVID Cases in 20 Days; Country Overwhelmed as ‘China Model’ on Virus Fails -
Surprising Study on Omicron’s Origin Retracted After Authors Discover Contaminated Samples -
China Reports New Omicron Variant Spreading in 9 Provinces; Populace Fearful, Mortuaries Overwhelmed -
Omicron BQ COVID-19 Variants Now Make Up Over Half of US Cases: CDC -
Australians Told to Avoid People as COVID-19 ‘Variant Soup’ Looms -
Rapid Waning of COVID Vaccine Requires Reevaluation of Future Booster Campaigns: Study